CrunchBase : The Week’s Biggest Funding Rounds: Safe Superintelligence’s $2B Rai

The Week’s Biggest Funding Rounds: Safe Superintelligence’s $2B Raise Leads The Way

Another week and another big artificial intelligence round. All in all it was an active week with a half-dozen rounds of $100 million or more, with everything from AI to blockchain to biotech getting serious cash.

1. Safe Superintelligence, $2B, artificial intelligence: AI research lab Safe Superintelligence snatched its second big raise in fewer than seven months. SSI, co-founded by OpenAI‘s former chief scientist Ilya Sutskever, reportedly raised a $2 billion round at a $32 billion valuation led by Greenoaks Capital Partners. The startup, which is looking to develop safe artificial intelligence systems, raised a $1 billion round from a litany of big-name investors including Andreessen Horowitz and Sequoia Capital last September.

2. Mainspring Energy, $258M, energy: Mainspring Energy secured a $258 million Series F led by General Catalyst. The Menlo Park, California-based firm builds generators — a business that has become appealing to investors as artificial intelligence continues to suck down energy. The company already is shipping generators — which can provide 10s of megawatts of power — to U.S. data center customers this year. Founded in 2010, the company has raised $813 million, per Crunchbase.

3. Auradine, $153M, blockchain: Web3 funding has been on the rise, and this week saw a good-sized round. Santa Clara, California-based Auradine, a developer of sustainable Bitcoin mining and AI data center networking solutions, raised a $153 million Series C led by StepStone Group. Founded in 2022, Auradine has raised more than $300 million, per the company.

4. Glycomine, $115M, biotech: San Carlos, California-based Glycomine, a biotech startup developing new therapies for orphan diseases, announced a $115 million Series C led by funds managed by Abrdn, Advent Life Sciences and CTI Life Sciences Fund. The company plans to use the new cash to advance its lead candidate into a phase 2b clinical trial. Founded in 2013, the company has raised $195 million, per Crunchbase.

5. Science, $104M, biotech: A Neuralink competitor raised big this week with a $104 million round led by Khosla Ventures. The Alameda, California-based biotech — which was founded by a Neurolink co-founder, is working on both a brain implant system and a retina implant to treat eye diseases. Founded in 2021, the company has raised $177 million, per Crunchbase.

6. Hammerspace, $100M, data: San Mateo, California-based Hammerspace, a data platform for AI, raised a $100 million round led by Altimeter Capital. Founded in 2018, the company has raised nearly $157 million, per Crunchbase.

7. Attovia Therapeutics, $90M, biotech: San Carlos, California-based Attovia Therapeutics, which is developing biotherapeutics focused on immune-mediated diseases, closed a $90 million Series C led by Deep Track Capital. Founded in 2023, Attovia has raised $255 million, per Crunchbase.

8. (tied) Chapter, $75M, healthcare: New York-based Chapter, a Medicare navigation platform which helps seniors find coverage, raised a $75 million Series D led by Stripes. Founded in 2020, the company has raised $184 million, per Crunchbase.

8. (tied) Exaforce, $75M, cybersecurity: Exaforce locked up a $75 million Series A funding led by Khosla Ventures, Mayfield Fund and Thomvest Ventures. The San Jose, California-based startup is helping bring artificial intelligence agents to security operations centers. The idea is, with the help of data, to significantly reduce human-led SOC work while improving security outcomes.

10. Luma Financial Technologies, $63M, fintech: Cincinnati-based Luma Financial Technologies, a fintech for banks and brokers, closed a $63 million Series C led by Sixth Street. Founded in 2018, the company has raised $93 million, per Crunchbase.

Big global deals
The biggest raise this week outside the U.S. came from China.
  • Beijing-based Zelos, an AI-driven startup in the autonomous driving sector, raised a $200 million Series B.